Skip to main content
Veterinary Medicines

PERACEF - 10 mg/ml Suspension zur intramammären Anwendung für Rinder

Not authorised
This information is not available for this product.

Product identification

Medicine name:
PERACEF - 10 mg/ml Suspension zur intramammären Anwendung für Rinder
Active substance:
This information is not available for this product.
Target species:
  • Cattle (lactating cow)
Route of administration:
  • Intramammary use

Product details

Active substance and strength:
This information is not available for this product.
Pharmaceutical form:
  • Intramammary suspension
Withdrawal period by route of administration:
  • Intramammary use
    • Cattle (lactating cow)
      • Meat and offal
        2
        day
      • Milk
        120
        hour
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ51DD12
Authorisation status:
  • Revoked
Authorised in:
  • Austria
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Zoetis Osterreich GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Haupt Pharma Latina S.r.l.
Responsible authority:
  • Austrian Agency For Health And Food Safety
Authorisation number:
  • 8-00137
Date of authorisation status change:

Documents

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 15/05/2017

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 15/05/2017

Labelling

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 15/05/2017
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."